Reference health
Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study
1 of 85 checkable references need attention · checked 2026-08-16
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
marked retracted — notice via Crossref, record curated by Retraction Watch10.1371/journal.pone.0113398
Berberine Improves Kidney Function in Diabetic Mice via AMPK Activation
The 84 checked references that resolve
resolves10.1016/s0168-8227(01)00309-6
The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan
resolves10.1093/ndt/gfn406
Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance
resolves10.1038/ki.1991.187
Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes
resolves10.1681/ASN.2004100852
Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes
resolves10.1038/sj.ki.5000294
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
resolves10.1056/NEJMoa011303
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
resolves10.1002/14651858.CD006872.pub2
Prostaglandin E1 for preventing the progression of diabetic kidney disease
resolves10.1056/NEJMoa1007994
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
resolves10.1002/phar.1232
To
<scp>RAS</scp>
or Not to
<scp>RAS</scp>
? The Evidence for and Cautions with Renin‐Angiotensin System Inhibition in Patients with Diabetic Kidney Disease
resolves10.1053/j.ajkd.2018.03.022
SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review
resolves10.1016/j.ackd.2005.04.001
Use of Alternative Medicine by Patients With Stage 5 Chronic Kidney Disease
resolves10.1016/j.ackd.2005.03.007
Chinese Herbal Medicine in the Treatment of Chronic Kidney Disease
resolves10.1016/j.ackd.2005.03.004
Potential Benefits of Complementary Medicine Modalities in Patients With Chronic Kidney Disease
resolves10.1016/j.jep.2014.08.029
Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: A population-based case control study
resolves10.1016/j.jep.2009.08.046
Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models
resolves10.1016/j.jep.2010.10.012
Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy
resolves10.1016/j.jep.2008.05.015
Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats
resolves10.1111/j.1753-0407.2011.00130.x
Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications
resolves10.1016/j.abb.2008.04.022
Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose
resolves10.1016/j.ejphar.2012.10.003
Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway
resolves10.2174/1389202917666160808125645
Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies
resolves10.1002/14651858.CD008369.pub2
Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
resolves10.1016/j.jep.2015.04.002
Chinese herbal medicine network and core treatments for allergic skin diseases: Implications from a nationwide database
resolves10.1155/2020/5979708
Identifying the Chinese Herbal Medicine Network and Core Formula for Allergic Rhinitis on a Real‐World Database
resolves10.1186/s12906-019-2491-y
Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study
resolves10.1016/0006-291x(75)90508-2
Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin
resolves10.1126/science.347.6219.337-c
The Art and Science of Traditional Medicine Part 2: Multidisciplinary Approaches for Studying Traditional Medicine
resolves10.1016/S1875-5364(13)60037-0
Traditional Chinese medicine network pharmacology: theory, methodology and application
resolves10.3389/fphar.2019.00123
Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment
resolves10.1155/2018/6503126
Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology
resolves10.1371/journal.pone.0089123
A Network Pharmacology Approach to Understanding the Mechanisms of Action of Traditional Medicine: Bushenhuoxue Formula for Treatment of Chronic Kidney Disease
resolves10.1136/bmjopen-2013-004033
Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study
resolves10.1136/bmjopen-2013-004428
Association of polypharmacy with fall-related fractures in older Taiwanese people: age- and gender-specific analyses
resolves10.1016/0021-9681(87)90171-8
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
resolves10.1001/2012.jama.11975
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
resolves10.1016/j.jhealeco.2008.03.002
Hospital ownership and performance: Evidence from stroke and cardiac treatment in Taiwan
resolves10.1155/2013/125943
Identifying Core Herbal Treatments for Children with Asthma: Implication from a Chinese Herbal Medicine Database in Taiwan
resolves10.1016/j.jep.2013.04.052
Identifying core herbal treatments for urticaria using Taiwan’s nationwide prescription database
resolves10.1186/1758-2946-6-13
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
resolves10.1371/journal.pone.0015939
TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
resolves10.1093/nar/gkv1277
STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
resolves10.1093/nar/gku1003
STRING v10: protein–protein interaction networks, integrated over the tree of life
resolves10.7573/dic.2020-7-3
Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
resolves10.1056/NEJMoa011161
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
resolves10.1016/S0140-6736(15)00257-3
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
resolves10.1001/jama.2015.10081
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
resolves10.1186/s12933-017-0547-1
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
resolves10.3389/fphar.2020.00823
The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
resolves10.1155/2019/2697672
The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease
resolves10.1126/scitranslmed.aav4754
Cyclin G1 and TASCC regulate kidney epithelial cell G
<sub>2</sub>
-M arrest and fibrotic maladaptive repair
resolves10.3389/fphar.2020.601325
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
resolves10.1038/nrneph.2015.3
Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD
resolves10.1007/s13105-020-00743-3
Inhibitor of growth 2 regulates the high glucose-induced cell cycle arrest and epithelial-to-mesenchymal transition in renal proximal tubular cells
resolves10.1093/ndt/gfu230
Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury
resolves10.1080/15287390600751322
Familial Characteristics of Kidney-Yang Deficiency and Cold Syndrome
resolves10.1142/S0192415X09006953
Identification of Linkage Disequilibrium SNPs from a Kidney-Yang Deficiency Syndrome Pedigree
resolves10.1093/ecam/neq069
Observations on Copy Number Variations in a Kidney‐yang Deficiency Syndrome Family
resolves10.1111/j.1440-1797.2008.01061.x
Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid
The 6 references without a DOI — listed, not checked
no DOI — not checkedref55
no DOI — not checkedDepartment of Chinese Medicine and Pharmacy of the Ministry of Health and Welfare, Taiwan2021-04-27https://dep.mohw.gov.tw/DOCMAP/lp-874-108.html
no DOI — not checkedSTITCH2021-04-27http://stitch.embl.de/
no DOI — not checkedReactome2021-04-27https://reactome.org/
no DOI — not checkedNodeXLCodePlex2021-04-27https://archive.codeplex.com/?p=nodexl
no DOI — not checkedDiabetic NephropathyGraphSpace2021-04-27https://graphspace.org/graphs/31998
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-16 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2196/27614"><img src="https://citestamp.com/citestamped/10.2196/27614/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2196/27614)